Synthesis of New Amino-1,5-Benzodiazepine and Benzotriazole Derivatives from Dimedone by Bellara Nedjar-Kolli et al.
ORIGINAL ARTICLE          
 
The article was published by Academy of Chemistry of Globe Publications 
www.acgpubs.org/OC/index.htm © Published 10/24/2008 EISSN:1307-6175 
 
 
 
Org. Commun. (2008) 1:3 62-68 
 
Synthesis of new amino-1,5-benzodiazepine and benzotriazole 
derivatives from dimedone 
 
 
Norah Bennamane, Rachedine Kaoua, Lamouri Hammal and Bellara 
Nedjar-Kolli
* 
Laboratory of Applied Organic Chemistry, University of Sciences and Technology 
Houari Boumediene, BP 32, El-Alia, Algiers, Algeria. 
 
(Received July 14, 2008; Revised September 29, 2008;  Accepted October 14, 2008) 
 
Abstract: High-yielding syntheses of two unpublished series of amino-1,5-benzodiazepines derivatives 3 and 
1,2,3-benzotriazoles 4 bearing a dimedone moiety are respectively reported. Derivatives 3 were obtained by 
intramolecular cyclisation using cyanogenbromide of enaminone 2. On the other hand, when enaminones 2 were 
treated with sodium nitrite under acidic conditions, cyclisation led to benzotriazole 4. 
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1. Introduction 
 
The benzodiazepine nucleus is a pharmacophoric scaffold and represent a class of heterocycles 
with a wide range of biological applications.
1 Many of them are widely used as anticonvulsant, 
antianxiety, sedative, antidepressive, hypnotic and neuroleptic agents.
2-5 Some heterocycles containing 
benzodiazepines moiety were reported to possess anti inflammatory
6, antiviral
7, anti-HIV-1
8, 
antimicrobial
9 and antitumor
10 activities. Other than their biological importance, benzodiazepines are 
valuable syntons for the preparation of fused ring compounds, such as triazolo
11, thiazolo
12, imidazo
13 
and pyrimido-benzodiazepines.
14 It has been noticed that introduction of an additional ring to the 
benzodiazepine core tends to exert profound influence in conferring novel biological activities in these 
molecules.
11-15 Although many methods for synthesizing benzodiazepine ring systems have been 
reported, they continue to receive a great deal attention.
9,16-18 
 
Another class of heterocycles used as scaffolds in medicinal chemistry is devoted to 
benzotriazole derivatives. They exhibit useful pharmacological properties and clinical applications.
19-22 
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In addition to these considerable biological applications, benzotriazoles are important intermediates, 
protecting groups and final products in organic synthesis.
23 
In the course of our research and as part of our program involving the synthesis of new 
heterocyclic compounds having potential biological interest, we have already reported the synthesis of 
many pyranobenzodiazepines
24-31, pyranobenzodiazepin-2-thione and benzotriazoles derivatives
32 
using enaminolactones as starting material. Recently, reactions of 5-amino-3-methyl-1H-pyrazole with 
dimedone and aldehydes was reported to give regioselectivelly tricyclic linear 3,7,7-trimethyl-4,7,8,9-
tetrahydro-2H-pyrazolo[3,4-b]quinolin-5(6H)-ones.
33 
In pursuance of our interests for investigating the reactivity of enaminones towards 
electrophile reagents we now extend the scope of these reactions to an other active compound the 5,5-
dimethylcyclohexan-1,3-dione(dimedone). They appear in a natural tricyclic heterocycle 
Benzylhiocrellidone isolated from sponge Crella spinulata
34-35  and is an effective synton in the 
synthesis of several polyheterocyclic compounds.
36-38 As expected, we get access to 1,5-
benzodiazepines 3 and Benzotriazoles 4 fused and linked respectively to a dimedone moiety (Scheme 
1).  
 
2. Results and discussion  
We have previously demonstrated that the enaminolactones intermediates allowed versatile 
access to different heterocycles
24-30, depending on the nature of electrophile used. In this work 
intermediate 2, obtained by reaction of dimedone with substituted o-phenylenediamines under similar 
conditions to already described procedure
24, was used as starting point for the synthesis of 
benzodiazepines 3 and benzotriazoles 4 according to our synthetic pathways which are outlined in the 
scheme 1. 
 
 
O
CH3
CH3
O
CH3
CH3
O
H
N
N+
H2N
H
Br-
X H2N
H2N
H
N
H2N
CH3
CH3
O
X
CH3
CH3
O
N
N N
X
X
1 3
EtOH, EtOH,
2
4
BrCN
NaNO2 / HCl
 
 
Scheme 1: Intramolecular cyclisations of enaminones 2 
 
Treatment of 2 with 1 equivalent of cyanobromide proceeds smoothly in refuxing, yielding by 
filtration product 3 in high purity. Amino-1,5-benzodiazepine and benzotriazole 
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As shown in scheme 2, the formation of seven membered ring 3 was due to the nucleophilic 
attack on the iminium ion by the adjacent electron-rich double bond of the dimedone moiety. 
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Scheme 2: Postulated mechanism for the formation of compounds 3 and 4 
 
 
Table 1: Physico-chemical data of derivatives 3a-c and 4a-c 
 
Compounds  X  Yields [%]  Time (h)  mp (ºC) 
3a  H 45 4  274-276 
3b  CH3 49  4  280-282 
3c  Cl 30  6  292-294 
4a  H 86 1  180-182 
4b  CH3 77  1  190-192 
4c  Cl 65  1  200-202 
 
 
Similarly the reaction of binucleophilic enaminone intermediates 2 with sodium nitrite under 
acidic conditions according to a described procedure,
36-38 allowed in all cases a single product 4 
bearing a dimedone moiety in good yield (table-1). The probable mechanism in this case seems to be 
the diazotization of the primary amine of 2, thus the formed diazo salt undergo cyclization, by 
nucleophilic attack of the secondary amino group leading to a triazole nucleus. The formation of 
benzotriazepine that would result from an intramolecular cyclization through the double bond of 
dimedone moiety as reported in the case of formation of benzodiazepines 3 was not observed. The 
purity and structures of the newly synthesized compounds were established by elemental analysis, IR, 
1H, 
13C NMR DEPT, and mass spectroscopic analysis. 
 
Compounds 3a-c exhibit in particular a 
1H NMR spectrum with a broadened singlet around 
9.6-9.8 ppm characterizing the presence of NH
+. In addition the complete lack of the ethylenic proton 
at the C-2 of the dimedone ring in the 
1H NMR is accompanied by absorption for the quaternary Bennamane et al.,, Org. Commun. (2008) 1:3 62-68 
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carbon of junction C-11a and C-11 of amidine bond at~ 96 ppm and~ 174 ppm respectively. The 
1H 
NMR spectra of 4a-c not only showed the absence of both signals of NH at 8.06-8.13 ppm and NH2 at 
4.75-5.19 ppm, but also indicate the presence of C(2)-H signal at 6.55-6.58 ppm. Moreover 
13C NMR 
spectrum contains a signal around 112.8-114.8 ppm assigned to the tertiary ethylenic carbon C-2 in the 
dimedone unit thus substantiate the formation of all suggested compounds.  
 
 
3. Conclusion 
 
In conclusion, enaminones 2 resulting from the commercially available dimedone and o- 
phenylenediamines derivatives constitute an interesting and efficient precursor for the synthesis of 
new 1.5-benzodiazepines and benzotriazoles systems which are condensed and linked respectively to a 
dimedone moiety. These products are expected to possess biological activities. 
 
 
4. Experimental 
 
Melting points were determined using a Stuart Scientific SMP1 melting point apparatus and 
were uncorrected. The IR spectra were recorded in KBr pellets on a Perkin-Elmer FTIR Paragon 1000 
spectrometer. The
 1H NMR spectra (400 MHz) and 
13C NMR (100.6 MHz) were run in DMSO- d6 on 
a Bruker Avance II spectrometer. Chemical shifts are given in ppm relative to TMS as internal 
standard. The positive-mode electrospray ionisation (ESI) mass spectra were recorded on a Perkin-
Elmer SCIEX API 300 spectrometer. The elemental analysis data were performed on a Thermo 
Electron Flash EA 1112. Chemicals were purchased from Aldrich and Acros Organics and used 
without further purification. 
 
 
General procedure for the preparation of compounds 2: 
 
To a magnetically stirred solution of 1 (20 mmol, 1 eq) in 100 ml of absolute ethanol was 
added 4- substituted -1,2-phenylenediamine compounds (20 mmol, 1eq), and the mixture was allowed 
to react at room temperature for 12 h (as monitored by TLC). The reaction mixture was concentrated 
by rotatory evaporation to a volume of 20 ml and then stored in a refrigerator for 3 h. The precipitate 
obtained was filtered, washed several times with diethyl ether and recrystallized from ethanol to afford 
compounds 2.Yields: 59-65 %.  
  
 
General procedure for the preparation of compounds 3: 
 
Cyanobromide 3M soln. EtOH (2.3 mmol, 1.15 eq) was added dropwise to a magnetically 
stirred solution of 2 (2 mmol, 1 eq) in ethanol 15 ml over a period of 30 min at room temperature. The 
mixture was then heated under reflux for 4-6 h. The precipitate formed was collected by filtration. 
Recrystallization from the proper solvent furnished the desired products 3a-c as yellow solid.  
  
11-amino-3,3-dimethyl-2,3,4,5-tetrahydro-1H-dibenzo[b,e][1,5]diazepin-1-one hydrobromide 
(3a).  Yield: 45%. IR (KBr): 3443-3250 (NH,NH2); 1652 (C=O), 1580 (C=N) cm
-1. 
1H NMR (400 
MHz, DMSO-d6) (￿/ppm): 1.01 (s, 6H, 2CH3), 2.34 (s, 2H, NC-CH2), 2.73 (s, 2H, OC-CH2), 6.89-7.22 
(m, 4H, Ar), 8.55 (s, br, 1H, NH), 9.72 (s, br, 1H, NH), 10.65 (s, 1H, NH2), 10.73 (s, 1H, NH2). 
13C 
NMR (100.6 MHz, DMSO-d6) (￿/ppm): 27.08, 29.21, 45.99, 50.65, 96.04, 121.31, 122.57, 126.06, 
128.11, 130.62, 131.02, 164.41, 174.28, 195.93. MS (ESI) m/z 256.5 [(M-HBr)
+, 16%]. Anal. Calcd. 
For. C15H17N3O, HBr: C, 53.58%; H, 5.40%; N,12.50%. Found: C, 53.37 %; H, 5.20%; N. 12.29%. Amino-1,5-benzodiazepine and benzotriazole 
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11-amino-3,3,7-trimethyl-2,3,4,5-tetrahydro-1H-dibenzo[b,e][1,5]diazepin-1-onehydrobromide 
(3b). Yield: 49%. IR (KBr): 3431-3237 (NH,NH2), 1667 (C=O), 1596 (C=N) cm
-1. 
1H NMR (400 
MHz, DMSO-d6) (￿/ppm): 1.01 (s, 6H, 2CH3), 2.23 (s, 3H, Ar-CH3), 2.34 (s, 2H, NC-CH2), 2.71 (s, 
2H, OC-CH2), 6.70-7.05 (m, 3H, Ar), 8.53 (s, br, 1H, NH), 9.67 (s, br, 1H, NH), 10.61 (s, 1H, NH2), 
10.81 (s, 1H, NH2). 
13C NMR (100.6 MHz, DMSO-d6) (￿/ppm): 20.13, 27.06, 29.19, 46.00, 50.64, 
95.48, 121.45, 122.53, 126.45, 128.22, 130.47, 138.04, 164.41, 173.65, 195.85. MS (ESI) m/z 270.5 
[(M-HBr)
+, 22%]. Anal. Calcd. For. C16H19N3O, HBr: C, 54.87 %; H, 5.76 %; N, 12.00 %. Found: C, 
54.74 %; H, 5.74 %; N, 11.87 %. 
 
11-amino-7-chloro-3,3-dimethyl-2,3,4,5-tetrahydro-1H-dibenzo[b,e][1,5]diazepin-1-one 
hydrobromide (3c). Yield: 30%. IR (KBr): 3460-3255 (NH,NH2), 1660 (C=O), 1590 (C=N) cm
-1. 
1H 
NMR (400 MHz, DMSO-d6) (￿/ppm): 1.02 (s, 6H, 2CH3), 2.35 (s, 2H, NC-CH2), 2.73 (s, 2H, OC-
CH2), 6.90-7.22 (m, 3H, Ar), 8.60 (s, br, 1H, NH), 9.81 (s, br, 1H, NH), 10.75 (s, 1H, NH2), 10.92 (s, 
1H, NH2). 
13C NMR (100.6 MHz, DMSO-d6) (￿/ppm): 27.04, 29.20, 46.15, 50.69, 95.72, 121.01, 
121.8, 122.50, 126.00, 129.8, 130.44, 164.92, 173.85, 195.78. MS (ESI) m/z 290.5 [(M-HBr)
+, 10%]. 
Anal. Calcd. for. C15H16N3OCl, HBr: C, 48.60 %; H, 4.62 %; N, 11.34 %. Found: C, 48.32 %; H, 4.42 
%; N, 11.09 %. 
 
 
General procedure for the preparation of compounds 4: 
 
To an ice-cooled (0-5°C) and stirred solution of (2 mmol, 1eq) of the appropriate enaminones 
2 in 6 ml of an 1M solution of HCl a solution of sodium nitrite 0.165g (2.4 mmol, 1.2 eq) in10 ml of 
H2O was added drop by drop. After 20 min, the ice- bath was removed an the resulting solution was 
stirred for an additional hour. The precipitate obtained was collected by filtration and washed with 
H2O. Recrystallization from ethyl acetate/petroleum ether gave the target compounds 4a-c. 
 
3-(1H-Benzotriazol-1-yl)-5,5-dimethylcyclohex-2-en-1-one (4a). Yield: 86%. IR (KBr): 1669 
(C=O), 1629 (C=N) cm
-1. 
1H NMR (400 MHz, DMSO-d6) (￿/ppm): 1.17 (s, 6H, 2CH3), 2.43 (s, 2H, 
NC- CH2), 3.25 (s, 2H, OC- CH2), 6.59 (s, 1H, NC=CH), 7.54-8.25 (m, 4H, Ar).
13C NMR (100.6 
MHz, DMSO-d6) (￿/ppm): 27.63, 32.80, 40.00, 50.12, 112.80, 114.34, 120.13, 125.50, 129.56, 130.87, 
146.16, 152.18, 198.05. MS (ESI) m/z 242.0 [(M
+-H)
+, 100%], 264.0 [(M
+-Na)
+, 65%]. Anal. Calcd. 
For. C14H15N3O: C, 69.69 %; H, 6.27 %; N, 17.41 %. Found: C, 69.88 %; H, 6.22 %; N, 17.25 %. 
 
5,5-dimethyl-3-(5-methyl-1H-benzotriozol-1-yl)cyclohex-2-en-1-one (4b). Yield: 77%. IR (KBr): 
1667 (C=O), 1626 (C=N) cm
-1. 
1H NMR (400 MHz, DMSO-d6) (￿/ppm): 1.15(s, 6H, 2CH3), 2.41 (s, 
2H, NC-CH2), 2.50 (s, 3H, Ar-CH3), 3.23 (s, 2H, OC-CH2), 6.55 (s, 1H, NC=CH), 7.53-7.99 (m, 3H, 
Ar). 
13C NMR (100.6 MHz, DMSO-d6) (￿/ppm): 20.68, 27.65, 32.76, 40.06, 50.11, 112.37, 113.82, 
119.05, 129.29, 131.38, 135.36, 146.78, 152.21, 198.08. MS (ESI) m/z 256.5 [(M
+-H)
+, 100 %], 278 
[(M
+-Na)
+, 47%] Anal. Calcd. for. C15H17N3O: C, 70.56 %; H, 6.71 %; N, 16.46 %. Found: C, 70.74 
%; H, 6.55 %; N, 16.28 %. 
 
 
3- (5-chloro-1H-Benzotriazol-1-yl-5,5-dimethylcyclohex-2-en-1-one (4c). Yield: 65%. IR (KBr): 
1670 (C=O), 1630 (C=N) cm
-1. 
1H NMR (400 MHz, DMSO-d6) (￿/ppm): 1.16 (s, 6H, 2CH3), 2.43 (s, 
2H, NC-CH2), 3.22 (s, 2H, OC- CH2), 6.58 (s, 1H, NC=CH), 7.71-8.40 (m, 3H, Ar). 
13C NMR (100.6 
MHz, DMSO-d6) (￿/ppm): 27.61, 32.81, 39.92, 50.10, 114.38, 115.01, 119.41, 129.74, 129.81, 129.87, 
146.83, 151.82, 198.01. MS (ESI) m/z 276.0 [(M
+-H)
+, 100%]. 298.0 [(M
+-Na)
+, 43%]. Anal. Calcd. 
For. C14H14ClN3O: C, 60.98 %; H, 5.12 %; N, 15.24 %. Found: C, 60.72 %; H, 4.93 %; N, 14.92 %. 
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